First Horizon Advisors, Inc. 10x Genomics, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.22 Billion
- Q1 2024
A detailed history of First Horizon Advisors, Inc. transactions in 10x Genomics, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,090 shares of TXG stock, worth $20,110. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,090
Previous 846
28.84%
Holding current value
$20,110
Previous $47,000
14.89%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding TXG
# of Institutions
311Shares Held
92MCall Options Held
267KPut Options Held
62.1K-
Vanguard Group Inc Valley Forge, PA9.1MShares$168 Million0.01% of portfolio
-
Baillie Gifford & CO7.42MShares$137 Million0.22% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl6.28MShares$116 Million1.68% of portfolio
-
Black Rock Inc. New York, NY6.01MShares$111 Million0.01% of portfolio
-
Morgan Stanley New York, NY5.16MShares$95.3 Million0.02% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.75B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...